Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Congenital Adrenal Hyperplasia is a genetic disorder with two forms, causing symptoms like early puberty and severe acne, but can be identified through screening and treated with glucocorticoids.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

In late pregnancy, allopregnanolone reduces stress responses in rats by affecting brain chemicals.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Spironolactone most effective for hirsutism, but has side effects.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Finasteride helps reduce heart issues and improves heart function.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

New treatments aim to improve thin endometrium to help more couples with infertility.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.